Delivery Order SPE2DB20D1004-SPE2DB24FF8H9

Award Date 4/17/24
Potential Completion Date 4/18/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,288.88, is for the procurement of the BREZTRI AEROSPHERE INHALER 10.7GM medical product. The contract has an ultimate completion date of February 24, 2025 and is a Firm Fixed Price contract type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of BREZTRI AEROSPHERE INHALER 10.7GM. The contract has a total ceiling value of $2,861.57 and runs through February 3, 2025. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of a pharmaceutical product called BREZTRI AEROSPHERE INHALER 10.7GM. The contract has a ceiling value of $1,371.06 and is a firm fixed-price delivery order with a completion date of November 10, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BREZTRI AEROSPHERE INHALER 10.7GM. The contract has a firm fixed price of $5,543.23 and a period of performance through September 12, 2024. There is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,950.21 firm fixed price delivery order is for the procurement of BREZTRI AEROSPHERE INHALER 10.7GM, a pharmaceutical product. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BREZTRI AEROSPHERE INHALER 5.9GM. The contract has a firm fixed price of $1,512.67 and a completion date of February 26, 2025. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Breztri Aerosphere inhalers. The contract has a ceiling value of $1,575.60 and a completion date of February 19, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of BREZTRI AEROSPHERE INHALER 10.7GM. The $2,586.63 firm fixed price contract has a completion date of December 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Breztri Aerosphere Inhaler 10.7 grams. The contract has a firm-fixed price of $10,929.04 and a period of performance running through August 26, 2024. This order is under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,849.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of BREZTRI AEROSPHERE INHALER 10.7GM. The contract has an ultimate completion date of January 28, 2025 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF8H9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BREZTRI AEROSPHERE INHALER 10.7GM. The contract has a ceiling value of $1,822.78 and runs through April 18, 2024. It is a firm fixed-price contract, without any set-aside designation, indicating open competition.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 2/27/25, 12:19 PM